Indeed, early studies on cholera vaccine candidates (36, 37) and more recently on other ETEC vaccine candidates (15, 38) showed that parenteral immunization of a protein- or lipopolysaccharide (LPS)-based vaccine candidate induces IgG and/or IgA antibodies to protect against cholera or ETEC diarrhea. This evidence concerns the gene CD79A and vibrio infectious disease.